Therapeutic Solutions International Returns to Fully Reporting Status with SEC
06 juil. 2017 09h22 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - July 06, 2017) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI), announced today that it has recently completed all of its regulatory filings to return to...
Therapeutic Solutions Subsidiary, SandBox Dental Labs, files 510(k) with FDA
26 juin 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 26, 2017) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that their majority-owned subsidiary, SandBox Dental Labs, Inc., has filed a...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
12 juin 2017 08h55 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 12, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary, Emvolio, Inc.The...
Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
05 juin 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 05, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a new patent for a biologic product called "MemoryMune".The...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
01 juin 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 01, 2017) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary Emvolio, Inc.The...
Therapeutic Solutions files new Patent on Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof
22 mai 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 22, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent covering a repurposing of the FDA cleared drug...
Therapeutic Solutions International Announces Exclusive Patent License Agreement to innaMune with its Subsidiary Emvolio, Inc.
18 mai 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 18, 2017) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary, Emvolio, Inc. The...
Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator
16 mai 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 16, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a novel blood derived stimulator of innate immune...
Therapeutic Solutions International Announces Exclusive Patent License Agreement with its Subsidiary Emvolio, Inc.
10 mai 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 10, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary Emvolio, Inc. The...
Therapeutic Solutions files new Patent on Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants
09 mai 2017 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 09, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a nutraceutical product called "Cancer Metabolic...